NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 12 min 20 sec ago
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-215 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support innovative research that will inform our understanding of the mechanisms underlying the formation of structural birth defects using animal models in conjunction with human translational/clinical approaches. Applicants are encouraged to take advantage of advances in genetics, omics methods (genomics, proteomics, metabolomics, etc.), and synthetic biology, biochemical and other approaches to developmental biology research to identify specific genetic, epigenetic, environmental, or gene/environment interactions associated with the formation of, susceptibility to, and variability of structural birth defects in human populations.
Categories: Job Watch, Literature Watch
Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-223 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support mechanistic studies on host cell death pathways and immune responses to Mycobacterium tuberculosis (Mtb) and Mtb/HIV co-infection to identify immune targets for development of host-directed therapies.
Categories: Job Watch, Literature Watch
Notice of Correction to RFA-DA-23-053, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)"
Notice NOT-DA-22-066 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-058 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the NIAID CDSMC, which will support a broad range of critical support services, including data management and processing, safety and pharmacovigilance management and processing, and sample tracking systems for NIAID-funded clinical trials, integrated studies of underlying mechanisms, clinical studies (e.g., longitudinal studies, genetic studies, etc.), and studies to identify and validate surrogates/biomarkers of immune-mediated diseases in the areas of asthma and allergic diseases, autoimmune diseases, and transplantation.
Categories: Job Watch, Literature Watch
Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-057 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for a Transplantation Statistical and Clinical Coordinating Center (T-SCCC) to provide a broad range of support critical for the design, development, execution, and analysis of clinical research carried out by multiple NIAID-supported programs in transplantation. The scope is to support the study teams with statistical design and analysis, protocol development, and final analysis of study findings. In addition, the T-SCCC will support the mechanistic studies by providing biospecimen labeling, shipping, specimen tracking, and kits and/or bulk supplies for specimen collection. Finally, the T-SCCC will work collaboratively with the Clinical Data and Safety and Monitoring Center (CDSMC) that will provide data management for the Transplantation clinical trials. The type of research for which support will be provided includes clinical trials, integrated studies of underlying mechanisms, clinical studies (e.g., longitudinal studies, genetic studies, etc.), and studies to identify and validate surrogates/biomarkers.
Categories: Job Watch, Literature Watch
Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-054 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for an Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) to provide a broad range of support critical for design, development, execution, and analysis of clinical research in allergic diseases and asthma. The major clinical research programs to be supported by the AA-SCCC include the Atopic Dermatitis Research Network, Consortium for Food Allergy Research, Childhood Asthma in Urban Settings Clinical Research Network, and Immune Tolerance Network. The AA-SCCC also may support Investigator-Initiated Clinical Trials (IICT), and other clinical trial/study activities funded by NIAID. The types of research for which support will be provided include clinical trials, integrated studies of underlying mechanisms, clinical studies (e.g., longitudinal observational studies, genetic studies, etc.), and studies to identify and validate surrogates/biomarkers.
Categories: Job Watch, Literature Watch
Notice of Correction to Key Dates for RFA-NS-22-040 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)"
Notice NOT-NS-22-112 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Building Infrastructure for Precision Medicine Research on Minority Health and Disparities in Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (UH2/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-020 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to promote collaborative research programs to support the development of infrastructure for precision medicine approaches for minority health and health disparities in AD/ADRD. This FOA serves as a catalytic opportunity for investigators to focus on populations underrepresented in AD/ADRD research, to build resources that include neurobiological, environmental, behavioral, and social science data, and to initiate innovative, integrated, and expanded studies of individuals from these populations.
Categories: Job Watch, Literature Watch
New NIH "FORMS-H" Grant Application Forms and Instructions Coming for Due Dates on or after January 25, 2023
Notice NOT-OD-22-195 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Findings of Research Misconduct
Notice NOT-OD-22-197 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Upcoming Prize Competition Announcement for the RADx Tech for Maternal Health Challenge
Notice NOT-HD-22-035 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Implementation Details for the NIH Data Management and Sharing Policy
Notice NOT-OD-22-189 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional)
Funding Opportunity RFA-AG-23-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from institutions proposing to develop, or renew, a Resource Center for Minority Aging Research (RCMAR) that focuses on behavioral and social science research in a key area related to Alzheimers disease (AD) and AD-related dementias (ADRD). The goal of the AD/ADRD RCMAR program is two-fold: (1) to diversify the AD/ADRD research workforce in priority areas of social, behavioral, psychological, and economic research related to AD/ADRD by mentoring promising scientists from diverse backgrounds; and 2) to develop a research and mentoring infrastructure to foster rigorous research and lead to scientific advances in priority areas of behavioral and social science related to AD/ADRD, including, but not limited to, the following: cognitive and dementia epidemiology, behavioral and social pathways to AD/ADRD, early psychological and functional changes, AD/ADRD prevention, dementia care, caregiving/care partners, and AD/ADRD health disparities and health inequities. To achieve the goal of the AD/ADRD RCMAR program, applications should propose multipronged, collaborative approaches in a supportive environment that embraces, integrates, and strengthens diversity, equity, inclusion, and accessibility (DEIA).
Categories: Job Watch, Literature Watch
Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional)
Funding Opportunity RFA-AG-23-026 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from institutions proposing to develop, or renew, a Resource Center for Minority Aging Research (RCMAR) that focuses on behavioral and social science research in a key area related to aging and/or to health disparities in older adults. Successful applications will propose the use of multipronged collaborative approaches in a supportive environment that embraces, integrates, and strengthens diversity, equity, inclusion, and accessibility (DEIA), to achieve the two-fold goal of the RCMAR program: 1) to diversify the research workforce in priority areas of social, behavioral, psychological, and economic research on aging by mentoring promising scientists from diverse backgrounds; and 2) to develop a research and mentoring infrastructure to foster rigorous behavioral and social science research on aging in a high priority research area, that can advance aging-relevant scientific discoveries, lead to the elimination of health disparities and health inequities, and improve the health and well-being of older adults who are members of NIAs Priority Populations, as specified in the NIA Health Disparities Research Framework.
Categories: Job Watch, Literature Watch
Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
Funding Opportunity RFA-AG-23-027 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to develop and maintain a coordinating center (CC) for the Resource Centers for Minority Aging Research (RCMAR) program. The RCMAR program supports behavioral and social research on aging, health disparities in older adults, and Alzheimers disease and Alzheimers disease related dementias (AD/ADRD), through the development of research infrastructure and mentorship of early career scientists from diverse backgrounds. The primary responsibilities of the RCMAR CC are to: coordinate and provide logistical support to RCMAR Centers; facilitate cooperation and collaboration across RCMAR Centers; create and maintain an interactive RCMAR CC website; identify and share research and training resources and materials; provide support, technical assistance, and resources to early career investigators; and perform program analysis and evaluation. The CC will also develop and implement strategies to enhance the visibility of the RCMAR program and behavioral and social research on aging and AD/ADRD as a whole, and to communicate the importance and value of diversity, equity, inclusion, and accessibility (DEIA) in the aging and AD/ADRD research enterprise.
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional)
Notice NOT-OD-22-142 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation
Notice NOT-AI-22-056 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Information: National Institute on Minority Health and Health Disparities (NIMHD) Award to Morehouse School of Medicine Due to Congressional Earmark
Notice NOT-MD-22-024 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
Funding Opportunity PAR-22-222 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy; or multiple non-HIV STI or HIV/STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development, and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety, and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.
Categories: Job Watch, Literature Watch
Notice of Correction to PAR-22-188, NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
Notice NOT-CA-22-119 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch